<PAGE 1>

        UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                                
                      WASHINGTON, DC  20549
                                
                                
                            FORM 10-Q
                                
   (MARK ONE) QUARTERLY REPORT / X / OR TRANSITION REPORT /  /
               PURSUANT TO SECTION 13 OR 15(d) OF
               THE SECURITIES EXCHANGE ACT OF 1934



For the quarter ended
January 31, 1998                       Commission File No. 1-5865



                     GERBER SCIENTIFIC, INC.
                ----------------------------------
                               
                   (Exact name of Registrant as
                    specified in its charter)



           CONNECTICUT                             06-0640743
 -------------------------------             -----------------------
               
 (State or other jurisdiction of                  (IRS Employer
  incorporation or organization)               Identification No.)


 83 Gerber Road West, South Windsor, Connecticut       06074
------------------------------------------------- ---------------
                       
    (Address of principal executive offices)         (Zip Code)
                                                          
                                                          
                                                          
Registrant's Telephone Number, including area      (860) 644-1551
code                                              ---------------


Indicate  by check mark whether the registrant (1) has filed  all
reports  required  to be filed by Section  13  or  15(d)  of  the
Securities  Exchange Act of 1934 during the preceding  12  months
(or  for such shorter period that the registrant was required  to
file  such  reports)  and  (2) has been subject  to  such  filing
requirements for the past 90 days.


                     Yes  / X / .   No /    /.

At January 31, 1998, 22,592,275 shares of common stock of the
Registrant were outstanding.


<PAGE 2>

                     GERBER SCIENTIFIC, INC.
                        AND SUBSIDIARIES
            CONTENTS OF QUARTERLY REPORT ON FORM 10-Q
                                
                 Quarter Ended January 31, 1998


                                                             PAGE



Part I - Financial Information

  Item 1. Consolidated Financial Statements:

           Statement of Earnings for the three months
           ended January 31, 1998 and 1997                   2
           
           Statement of Earnings for the nine months ended
           January 31, 1998 and 1997                         3
           
           Balance Sheet at January 31, 1998 and
           April 30, 1997                                    4
           
           Statement of Cash Flows for the nine months
           ended January 31, 1998 and 1997                   5
           
           Notes to Financial Statements                     6
           
           Independent Accountants' Report                   9

  Item 2. Management's Discussion and Analysis of
           Financial Condition and Results of Operations    10


Part II - Other Information

  Item 1. Legal Proceedings                                 14

  Item 6.  Exhibits and Reports on Form 8-K                 14


Signature                                                    15

Exhibit Index                                                16

                                       1

<PAGE 3>

            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
               CONSOLIDATED STATEMENT OF EARNINGS

------------------------------------------------------------
                                         In thousands
                                  (except per share amounts)
------------------------------------------------------------
Three Months Ended January 31,             1998       1997
------------------------------------------------------------
                                                    
Revenue:                                            
                                                    
  Product sales                        $ 92,559    $ 83,041
  Service                                12,277      11,550
                                        -------     -------
                                        104,836      94,591
                                        -------     -------
                                                    
Costs and Expenses:                                 
                                                    
  Cost of product sales                  48,743      44,825
  Cost of service                         7,301       7,457
  Selling, general and administrative    32,219      29,335
  Research and development expenses       7,746       7,659
                                        -------     -------
                                         96,009      89,276
                                        -------     -------
                                                    
Operating income                          8,827       5,315
                                                    
Other income                                378         717
Interest expense                            (90)        (88)
                                        -------     -------
                                                    
Earnings before income taxes              9,115       5,944
                                                    
Provision for income taxes                2,900       1,800
                                        -------     -------
                                                    
Net earnings                            $ 6,215     $ 4,144
                                        =======     =======
                                                    
Per share of common stock:                          
  Basic                                 $   .28     $   .18
  Diluted                               $   .27     $   .18
                                                    
  Dividends                             $   .08     $   .08
                                                    
Average shares outstanding:                         
  Basic                                  22,586      23,261
  Diluted                                23,025      23,357


                     See Accompanying Notes
          
                                  2

<PAGE 4>
        
            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
               CONSOLIDATED STATEMENT OF EARNINGS

-----------------------------------------------------------------
                                              In thousands
                                       (except per share amounts)
-----------------------------------------------------------------
Nine Months Ended January 31,                1998          1997
-----------------------------------------------------------------
                                                        
Revenue:                                                
                                                        
  Product sales                            $274,703     $240,919
  Service                                    35,486       34,431
                                           --------     --------
                                            310,189      275,350
                                           --------     --------
                                                        
Costs and Expenses:                                     
                                                        
  Cost of product sales                     148,623      132,027
  Cost of service                            22,681       21,819
  Selling, general and administrative        94,926       88,310
  Research and development expenses          23,099       21,868
                                           --------     --------
                                            289,329      264,024
                                           --------     --------
                                                        
Operating income                             20,860       11,326
                                                        
Other income                                  3,388        4,017
Interest expense                               (266)        (261)
                                           --------     --------
                                                        
Earnings before income taxes                 23,982       15,082
                                                        
Provision for income taxes                    7,700        4,200
                                           --------     --------
                                                        
Net earnings                               $ 16,282     $ 10,882
                                           ========     ========
                                                        
Per share of common stock:                              
  Basic                                    $    .71     $    .47
  Diluted                                  $    .70     $    .47
                                                        
  Dividends                                $    .24     $    .24
                                                        
Average shares outstanding:                             
  Basic                                      22,863       23,234
  Diluted                                    23,354       23,352


                     See Accompanying Notes
 
                                  3


<PAGE 5>

            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
                   CONSOLIDATED BALANCE SHEET
                                
                                
                                             In thousands
--------------------------------------------------------------
                                       January 31,   April 30,
                                           1998         1997
--------------------------------------------------------------
                 Assets                                   
Current Assets:                                       
 Cash and short-term cash investments     $ 25,743    $ 9,503
 Accounts receivable                        93,489     92,378
 Inventories                                70,520     62,221
 Prepaid expenses                           13,411     13,702
                                          --------    --------
                                           203,163    177,804
                                          --------    --------
                                                      
Investments and long-term receivables       17,326     37,037
                                          --------    --------
Property, plant and equipment              129,543    121,447
 Less accumulated depreciation              62,039     58,883
                                          --------    --------
                                            67,504     62,564
                                          --------    --------
                                                      
Intangible assets                           57,898     56,687
 Less accumulated amortization              12,083     10,774
                                          --------    --------
                                            45,815     45,913
                                          --------    --------
Other assets                                   457      1,897
                                          --------    --------
                                          $334,265    $325,215
                                          ========    ========
Liabilities and Shareholders' Equity                      
                                                      
Current Liabilities:                                  
 Notes payable                             $    --    $    --
 Current maturities of long-term debt          193        193
 Accounts payable                           26,702     17,453
 Accrued compensation and benefits          15,010     14,038
 Other accrued liabilities                  18,951     18,458
 Deferred revenue and litigation award       6,747      6,249
 Advances on sales contracts                 7,403      2,465
                                          --------    --------
                                            75,006     58,856
                                          --------    --------
Noncurrent Liabilities:                               
 Deferred income taxes                      11,687     11,193
 Long-term debt                              7,002      7,145
                                          --------    --------
                                            18,689     18,338
                                          --------    --------
Contingencies and Commitments                            
                                                         
Shareholders' Equity:                                    
 Preferred stock, no par value; authorized               
  10,000,000 shares; no shares issued              --          --
 Common stock, $1.00 par value; authorized               
  65,000,000 shares; issued                              
  23,392,275 and 23,306,900 shares             23,392      23,307
 Paid-in capital                               37,008      36,100
 Retained earnings                            198,685     187,880
 Cumulative translation component              (2,065)        734
 Treasury stock, at cost (800,000 shares)     (16,450)         --
                                              --------   --------
                                              240,570     248,021
                                             --------    --------
                                             $334,265    $325,215
                                             ========    ========
                                
                        
                                
                
                     See Accompanying Notes

                                4

<PAGE 6>

            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
              CONSOLIDATED STATEMENT OF CASH FLOWS

                                                    In thousands
--------------------------------------------------------------------

Nine Months Ended January 31,                     1998        1997
--------------------------------------------------------------------

CASH PROVIDED BY (USED FOR):                                
                                                            
Operating Activities                                        
  Net earnings                                   $16,282     $10,882
  Adjustments to reconcile net earnings to                  
   cash provided by operating activities:
     Depreciation and amortization                 9,655       8,876
     Deferred income taxes                           494       1,384
     Changes in operating accounts:                         
      Receivables                                   (778)     (9,914)
      Inventories                                 (8,299)        410
      Prepaid expenses                               291      (2,297)
      Accounts payable and accrued expenses       16,150      (5,550)
                                                 -------     -------
Provided by Operating Activities                  33,795       3,791
                                                 -------     -------
                                                            
Financing Activities                                        
  Purchase of common stock                       (16,450)         --
  Repayments of long-term debt                      (143)       (144)
  Exercise of stock options                          993         740
  Dividends on common stock                       (5,477)     (5,573)
                                                 -------     -------
                                                            
(Used for) Financing Activities                  (21,077)     (4,977)
                                                 -------     -------
                                                            
Investing Activities                                        
  Maturities of long-term debt securities         19,378      11,751
  Additions to property, plant and equipment     (13,109)     (9,861)
  Intangible and other assets                         52      (1,421)
  Other long-term investments                     (2,799)        541
                                                 -------     -------
                                                            
Provided by Investing Activities                   3,522       1,010
                                                 -------     -------
                                                            
Increase (Decrease) in Cash and Short-Term                  
  Cash Investments                                16,240        (176)
                                                            
Cash and Short-Term Cash Investments,                       
  Beginning of Period                              9,503       8,704
                                                 -------     -------
                                                            
Cash and Short-Term Cash Investments,            $25,743     $ 8,528
  End of Period                                  =======     =======



                     See Accompanying Notes
                               
                                 5

<PAGE 7>

            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
           NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1

The   consolidated  balance  sheet  at  January  31,  1998,   the
consolidated statements of earnings for the three- and nine-month
periods  ended  January 31, 1998 and 1997, and  the  consolidated
statement  of  cash  flows  for  the  nine-month  periods   ended
January  31, 1998 and 1997 are unaudited but, in the  opinion  of
the  Company, include all adjustments, consisting only of  normal
recurring accruals, necessary for a fair statement of the results
for the interim periods.  The results of operations for the nine-
month   period  ended  January  31,  1998  are  not   necessarily
indicative  of  the results to be expected for  the  full  fiscal
year.

NOTE 2

The classification of inventories was as follows (in thousands):

                      January 31, 1998   April 30, 1997
                      ----------------  ----------------
Raw materials and                       
  purchased parts        $52,570            $49,461
Work in process           17,950             12,760
                         -------            -------
                         $70,520            $62,221
                         =======            =======

NOTE 3

In February 1997, the Financial Accounting Standards Board issued
Statement of Financial Accounting Standards No. 128, Earnings Per
Share,  effective for financial statements for  both  annual  and
interim  periods ending after December 15, 1997.   Statement  128
replaced  the  previously  reported  primary  and  fully  diluted
earnings  per  share with basic and diluted earnings  per  share.
Unlike  primary  earnings  per share, basic  earnings  per  share
excludes   any   dilutive  effects  of  options,  warrants,   and
convertible securities.  Diluted earnings per share is similar to
the  previously reported fully diluted earnings per  share.   All
earnings  per share amounts for all periods have been  presented,
and  where  necessary, restated to conform to the  Statement  128
requirements.  This restatement had an immaterial impact  on  the
prior  period  earnings  per  share amounts  under  the  previous
method.

                               6

<PAGE 8>

The  following  table  sets forth the computation  of  basic  and
diluted earnings per share:

                         Three Months Ended        Nine Months Ended
                             January 31,              January 31,
                           1998        1997        1998         1997
                        ----------  ----------  ----------   ----------
Numerator:                                                              
 Net Income             $6,215,000  $4,144,000  $16,282,000  $10,882,000
                        ==========  ==========  ===========  ===========
Denominators:                                                           
 Denominator for                                                        
  basic earnings per                                                    
share--weighted-                                                        
  average shares                                                        
  outstanding           22,585,845  23,260,861   22,863,194   23,234,334
 Effect of dilutive                                                     
  securities:
  Employee stock                                                        
   options                 438,662      95,925      490,619      118,003
                        ----------  ----------   ----------   ----------
  Denominator for                                                       
   diluted earnings                                                     
   per share--adjusted                                                  
   weighted-average                                                     
   shares outstanding   23,024,507  23,356,786   23,353,813   23,352,337
                        ==========  ==========   ==========   ==========
Basic earnings per                                                      
 share                  $      .28  $      .18   $      .71   $      .47
                        ==========  ==========   ==========   ==========
Diluted earnings per                                                    
 share                  $      .27  $      .18   $      .70   $      .47
                        ==========  ==========   ==========   ==========

NOTE 4

Included  in  other  income  for  the  nine  month  period  ended
January  31, 1998 was a gain resulting from the final  settlement
of  the Company's UK patent litigation with Lectra Systemes, S.A.
of France, which added $1,563,000 to earnings before income taxes
and  approximately $1,000,000, or $.04 per share, to net  income.
Included  in  other  income  for  the  nine  month  period  ended
January  31,  1997  was  a  gain resulting  from  life  insurance
benefits  the  Company received upon the death of Mr.  H.  Joseph
Gerber  which added approximately $1,000,000, or $.04 per  share,
to net income.

NOTE 5

On  August 14, 1997 the Company purchased 800,000 shares  of  its
common  stock  from the estate of H. Joseph Gerber  for  a  total
of  $16,450,000,  or  $20.50  per  share  plus  transaction  fees
incurred.   The  reacquired shares are held  by  the  Company  as
treasury stock.

                               7

<PAGE 9>

            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES




With  respect to the unaudited consolidated financial  statements
of  Gerber Scientific, Inc. and subsidiaries at January 31,  1998
and  for the three- and nine-month periods ended January 31, 1998
and  1997,  KPMG  Peat Marwick LLP has made a  review  (based  on
procedures adopted by the American Institute of Certified  Public
Accountants)  and  not an audit, as set forth in  their  separate
report  dated February 18, 1998 appearing on page 9.  That report
does not express an opinion on the interim unaudited consolidated
financial information.  KPMG Peat Marwick LLP has not carried out
any  significant  or  additional audit tests beyond  those  which
would  have been necessary if their report had not been included.
Accordingly,  such  report  is not a "report"  or  "part  of  the
Registration Statement" within the meaning of Sections 7  and  11
of  the  Securities Act of 1933 and the liability  provisions  of
Section 11 of such Act do not apply.

                                 8

<PAGE 10>

                 INDEPENDENT ACCOUNTANTS' REPORT


To the Board of Directors and Shareholders of
Gerber Scientific, Inc.


We  have made a review of the consolidated statements of earnings
of  Gerber  Scientific, Inc. and subsidiaries for the three-  and
nine-month  periods  ended  January  31,  1998  and   1997,   the
consolidated  statement of cash flows for the nine-month  periods
ended  January  31,  1998 and 1997, and the consolidated  balance
sheet  as  of  January  31,  1998 in  accordance  with  standards
established  by  the  American  Institute  of  Certified   Public
Accountants.   We  have previously audited,  in  accordance  with
generally   accepted  auditing  standards,  and   expressed   our
unqualified  opinion  dated  May 22,  1997  on  the  consolidated
financial  statements  for the year ended  April  30,  1997  (not
presented  herein).  The aforementioned financial statements  are
the responsibility of the Company's management.

A review of interim financial information consists principally of
applying  analytical  review procedures  to  financial  data  and
making  inquiries  of  persons  responsible  for  financial   and
accounting  matters.  It is substantially less in scope  than  an
examination  in  accordance  with  generally  accepted   auditing
standards, the objective of which is the expression of an opinion
regarding   the   financial  statements   taken   as   a   whole.
Accordingly, we do not express such an opinion.

Based   on   our  review,  we  are  not  aware  of  any  material
modifications   that   should  be  made   to   the   accompanying
consolidated statements of earnings for the three- and nine-month
periods  ended  January  31,  1998  and  1997,  the  consolidated
statement of cash flows for the nine-month periods ended  January
31,  1998  and  1997,  or the consolidated balance  sheet  as  of
January  31,  1998  for them to be in conformity  with  generally
accepted   accounting  principles.  Also,  in  our  opinion   the
information in the accompanying consolidated balance sheet as  of
April 30, 1997 is fairly presented, in all material respects,  in
relation to the consolidated balance sheet from which it has been
derived.




/s/ KPMG PEAT MARWICK LLP


Hartford, Connecticut
February 18, 1998

                                   9

<PAGE 11>

            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
             MANAGEMENT'S DISCUSSION AND ANALYSIS OF
          FINANCIAL CONDITION AND RESULTS OF OPERATIONS


FINANCIAL CONDITION

The  Company's ratio of current assets to current liabilities was
2.7  to  1  at  January  31,  1998  compared  with  3  to  1   at
April  30,  1997.  Net working capital at January  31,  1998  was
$128.2   million,   an  increase  of  $9.2   million   from   the
beginning  of  the current fiscal year.  The Company's  cash  and
investments, both short- and long-term, totaled $42.9 million  at
January  31, 1998 compared with $46.1 million at the end  of  the
prior fiscal year.

Operating  activities  provided $33.8 million  in  cash  for  the
nine-month   period   ended  January  31,  1998   compared   with
$3.8 million provided by operating activities for the same period
last  year.  Cash generated by earnings and the non-cash  charges
for  depreciation  and  amortization in this  year's  first  nine
months  was  somewhat offset by growth in inventories.   However,
increases  in  accounts  payable related  primarily  to  improved
management of vendor payment cycles produced additional cash from
operations.

The principal non-operating uses of cash in the nine months ended
January  31,  1998  were  the  purchase  of  treasury  stock   of
$16.4  million,  additions to property, plant, and  equipment  of
$13.1  million,  and payment of dividends of $5.5  million.   The
Company  anticipates that capital expenditures  for  the  current
fiscal  year will be in the range of $15 million and  expects  to
fund these with cash on hand and cash from operations.

The  Company's  total debt at January 31, 1998 was $7.2  million,
down  slightly from April 30, 1997.  The ratio of total  debt  to
shareholders' equity was 3 percent at January 31, 1998,  compared
with  3 percent at April 30, 1997.  The Company believes its  low
ratio  of debt-to-equity is an important indicator of its ability
to borrow funds should needs arise.

RESULTS OF OPERATIONS

Combined  sales and service revenue for the three- and nine-month
periods   ended   January  31,  1998  increased   $10.2   million
(10.8  percent)  and $34.8 million (12.7 percent),  respectively,
from  the same periods last year.  The increases reflected higher
product  sales and slightly higher service revenue.  The  product
sales  increases  came predominantly from  higher  sales  of  the
Company's  fabric cutting systems and optical lens  manufacturing
equipment.  In addition, GGT Cutting Edge, an acquisition in  the
fourth quarter of last fiscal year, contributed $5.5 million  and
$12.5  million  of  the  third  quarter  and  year-to-date  sales
increases.

                                10

<PAGE 12>

The  consolidated gross profit margin in this year's  first  nine
months was 44.8 percent, which was slightly higher than the prior
year  margin  of  44.1  percent.  The consolidated  gross  profit
margin  in  this  year's third quarter of 46.5  percent  was  1.8
percentage  points  higher than the prior  year  margin  of  44.7
percent.  Gross profit margins on product sales were higher  this
year  in  both  the  third quarter and first  nine  months.   The
improvements  were caused primarily by favorable  volume  effects
from  higher  shipments of fabric cutting systems, especially  in
North  American  markets.   The higher  volume  of  shipments  of
optical lens manufacturing systems also contributed to the  third
quarter  margin increase.  These increases were partially  offset
by  higher  sales  of OEM-supplied equipment for the  electronics
industry  and  also  by  price discounting  on  computer-to-plate
imaging systems for the commercial printing market.

Service  gross  profit margins were higher in this  year's  third
quarter  but  slightly  lower for the  first  nine  months.   The
increase  in this year's third quarter service margin was  caused
primarily  by  the  heavier utilization of service  personnel  to
assist in new installations of fabric cutting systems.  On a year-
to-date  basis, this increase was offset by costs in the  current
year  associated  with  development of an  applications  training
revenue stream from the computer-to-plate systems businesses.

Selling,  general,  and administrative expenses  in  this  year's
third  quarter  and first nine months rose by  $2.9  million  and
$6.6  million,  respectively, from  last  year.   However,  as  a
percentage  of revenue, these expenses declined to  30.7  percent
and  30.6  percent in this year's third quarter  and  first  nine
months from 31 percent and 32.1 percent last year.  The increased
expenses  were  caused  primarily by  higher  marketing  expenses
associated  with major trade shows and also by the  inclusion  of
the  expenses  of  GGT Cutting Edge.  Partially offsetting  these
increases  was the effect of a cost reduction program implemented
at the Company's Gerber Garment Technology (GGT) subsidiary.

The Company continued to commit significant resources to research
and the development of new products.  R&D expense of $7.7 million
in  this year's third quarter and $23.1 million in the first nine
months  represented  7.4  percent of revenue  in  both  of  these
periods.   Although  R&D expense increased  from  the  comparable
prior  year  periods,  the percentage of R&D  expenses  to  sales
revenue  was lower this year.  The dollar increases were  related
primarily  to  the  development of new  signmaking  plotters  and
output  devices and the inclusion of the expenses of GGT  Cutting
Edge.   Management anticipates that this lower ratio  of  R&D  to
revenue will continue for the balance of the current year due  in
part  to  comparatively lower levels of development  spending  in
computer-to-plate imaging systems for the printing  industry  and
to growth in sales volume.

                               11

<PAGE 13>

Other  income in this year's third quarter and first nine  months
was lower than last year.  The year-to-date decrease relates to a
prior  year  gain of approximately $1.0 million ($.04 per  share)
from  life insurance benefits and lower interest income this year
resulting  from  a  smaller investment  portfolio  of  tax-exempt
municipal bonds.  Partially offsetting these items was a gain  in
the current year's first quarter from the final settlement of the
Company's  UK  patent  litigation with Lectra  Systemes  S.A.  of
France, amounting to $1.6 million ($.04 per share).

The provision rate for income taxes was 32.1 percent for the nine
months  ended January 31, 1998 compared with 27.8 percent in  the
comparable  prior  year period.  The lower  tax  rate  last  year
was  the result of the tax-exempt life insurance benefits and the
larger  amount  of tax-exempt interest income noted  above.   The
year-to-year  increase in the provision rate  also  reflects  the
higher  marginal  combined Federal and  state  income  tax  rates
associated  with  the higher levels of pre-tax  earnings  in  the
current year.

As  a  result of the above, net earnings increased in this year's
third  quarter to $6.2 million or $.27 diluted earnings per share
from  $4.1  million or $.18 diluted earnings per  share  in  last
year's  third  quarter.  For the first nine months, net  earnings
this year increased to $16.3 million or $.70 diluted earnings per
share  this  year  compared with $10.9 million  or  $.47  diluted
earnings per share last year.

YEAR 2000

The  Company is in the process of assessing its exposure  to  the
impact of the Year 2000 date issue.  The Year 2000 date issue can
affect  computer programs that use only two digits to identify  a
year  in  a date field.  The Company's products and key financial
and  operational systems are being reviewed and, where  required,
detailed plans have been, or are being, developed and implemented
on  a  schedule intended to permit the Company's computer systems
and  products  to continue to function properly.  The  Year  2000
date   conversion  effort  is  expected  to  increase  costs   in
fiscal  years  1999  and  2000 although cost  estimates  are  not
complete.  Management does not expect that these costs will  have
a  material  adverse impact on the Company's financial  position,
results of operations, or cash flows.  However, the Company could
be  adversely impacted by the year 2000 date issue if  suppliers,
customers,  and  other  businesses  do  not  address  this  issue
successfully.

                               12

<PAGE 14>

FORWARD-LOOKING STATEMENTS

This report includes forward-looking statements that describe the
Company's business prospects. Readers should keep in mind factors
that  could  have  an adverse impact on those  prospects.   These
include  political,  economic,  or  other  conditions,  such   as
recessionary  or  expansive  trends,  inflation  rates,  currency
exchange  rates,  taxes and regulations and  laws  affecting  the
business, as well as product competition, pricing, the degree  of
acceptance of new products to the marketplace, and the difficulty
of forecasting sales at various times in various markets.

                           13

<PAGE 15>

                   PART II - OTHER INFORMATION

Item 1.  Legal Proceedings

Form  10-Q for the quarter ended July 31, 1997 reported the final
settlement  of  the  Company's UK patent litigation  with  Lectra
Systemes, S.A. of France.


Item 6.  Exhibits and Reports on Form 8-K

(a)  Exhibits

     (10) Gerber  Scientific,  Inc. Profit and  Growth  Incentive
          Bonus Plan for the Fiscal Year Ending April 30, 1998.

     (15) Letter    regarding    unaudited   interim    financial
          information.

     (27) Financial data schedule.

(b)  Reports on Form 8-K

     No  Form  8-K  was filed during the quarter for  which  this
     report is filed.

                              14

<PAGE 16>


                            SIGNATURE


Pursuant  to the requirements of the Securities Exchange  Act  of
1934, the Registrant has duly caused this report to be signed  on
its behalf by the undersigned, thereunto duly authorized.




                               GERBER SCIENTIFIC, INC.
                              ------------------------
                                    (Registrant)




Date:   February 26, 1998   By:  / s / Gary K. Bennett
        ------------------       --------------------------------
                                
                                 Gary K. Bennett
                                 Senior Vice President, Finance
                                 and Principal Financial Officer

                                15

<PAGE 17>


                          EXHIBIT INDEX




Exhibit Index                                                 
    Number                    Exhibit                       Page
-------------                 -------                       ----
      10        Gerber  Scientific, Inc. Profit  and  
                Growth Incentive Bonus Plan for  the
                Fiscal Year Ending April 30, 1998.*
                                                      
      15        Letter  Regarding Unaudited  Interim  
                Financial Information.*
                                                      
      27        Financial Data Schedule.*             




*Filed herewith.

                                   16